Back to Search
MURALIDHAR BEERAM, M.D.
M.D.
Medical Oncology Physician
NPI: 1265426282IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
M1505(TX)
Education
OTHER
Class of 1994
Research & Publications (19)
Akt-induced endocrine therapy resistance is reversed by inhibition of mTOR signaling.
PMID 17693645·Ann Oncol·2007
8-other
Raf: a strategic target for therapeutic development against cancer.
PMID 16170185·J Clin Oncol·2005
4-observational
Targeting intracellular signal transduction. A new paradigm for a brave new world of molecularly targeted therapeutics.
PMID 12512384·Hematol Oncol Clin North Am·2002
6-review
Effects of topical emollient therapy on infants at or less than 27 weeks' gestation.
PMID 16708512·J Natl Med Assoc·2006
8-other
Phase I and pharmacokinetic study of cisplatin and troxacitabine administered intravenously every 28 days in patients with advanced solid malignancies.
PMID 19449006·Cancer Chemother Pharmacol·2009
3-trial
Phase I and pharmacokinetic study of XRP6258 (RPR 116258A), a novel taxane, administered as a 1-hour infusion every 3 weeks in patients with advanced solid tumors.
PMID 19147780·Clin Cancer Res·2009
3-trial
A phase 1 open-label, accelerated dose-escalation study of the hypoxia-activated prodrug AQ4N in patients with advanced malignancies.
PMID 18981010·Clin Cancer Res·2008
3-trial
Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group.
PMID 18445842·J Clin Oncol·2008
3-trial
Phase I and pharmacokinetic study of AI-850, a novel microparticle hydrophobic drug delivery system for paclitaxel.
PMID 17545535·Clin Cancer Res·2007
3-trial
Phase I and pharmacokinetic study of pemetrexed with high-dose folic acid supplementation or multivitamin supplementation in patients with locally advanced or metastatic cancer.
PMID 17473199·Clin Cancer Res·2007
3-trial
A phase I and pharmacokinetic study of pemetrexed plus irinotecan in patients with advanced solid malignancies.
PMID 17255275·Clin Cancer Res·2007
3-trial
A phase II, pharmacokinetic, and biologic study of semaxanib and thalidomide in patients with metastatic melanoma.
PMID 16736151·Cancer Chemother Pharmacol·2007
3-trial
Phase I, pharmacokinetic, and biological study of erlotinib in combination with paclitaxel and carboplatin in patients with advanced solid tumors.
PMID 17189413·Clin Cancer Res·2006
3-trial
Ileal atresia associated with Hirschsprung disease (total colonic aganglionosis).
PMID 16150333·J Pediatr Surg·2005
5-case
Positron emission tomography in the management of unknown primary head and neck carcinoma.
PMID 16027287·Arch Otolaryngol Head Neck Surg·2005
8-other
Emergent pericardiocentesis through a percutaneous silastic catheter in a premature infant: case report.
PMID 15118783·Clin Pediatr (Phila)·2004
5-case
Red blood cell transfusion practices in very low birth weight infants in 1990s postsurfactant era.
PMID 11688921·J Natl Med Assoc·2001
8-other
Hypothyroxinemia of prematurity: rite of passage or therapeutic necessity?
PMID 11125989·Tex Med·2000
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4383 MEDICAL DR
SAN ANTONIO, TX 78229 - Phone
- (210) 593-5700
Quick Facts
- NPI
- 1265426282
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 32
- Publications
- 19
Are you this provider?
Claim Your Profile